000534.SZ · 万泽股份
China A-shares · RS rating 13 · As of 2026-10-14
| Price | 19.70 CNY |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 11 / 10 / 86 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 16 / 21 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -14.7% |
| Distance from 52-week high | +58.7% |
| Market cap (USD) | $1.6B |